News Genentech buys NASH biotech Jecure Richard Staines inflammatory diseases, Jecure, M&A, NASH, Roche 0 Comment Roche’s Genentech unit has bought California biotech Jecure Therapeutics, which is researching drugs that could be used in Share X Genentech buys NASH biotech Jecure https://pharmaphorum.com/news/genentech-buys-nash-biotech-jecure/
